BPH-1358 free base is primarily utilized in research and development within the pharmaceutical industry. It is investigated for its potential therapeutic applications, particularly in the treatment of central nervous system (CNS) disorders. Researchers focus on its ability to modulate specific receptors or pathways that are implicated in neurological conditions, aiming to develop novel treatments for diseases such as depression, anxiety, or neurodegenerative disorders. Additionally, it may be studied for its pharmacokinetic properties to assess its suitability as a drug candidate. Its application is largely confined to preclinical studies, where it serves as a key compound for understanding biological mechanisms and optimizing drug efficacy and safety.